TARDBP and amyotrophic lateral sclerosis: Although PCA has been well studied in other disease models (e.g., AD and PD), it should be further studied in additional models of ALS, such as C9orf72 and TDP-43 ALS, to further elucidate its benefit for treating ALS in a diverse patient population.